Feed 300463.SZ
30

Maccura Biotechnology Co.Ltd

300463.SZ · SHZ

¥9.68 +2.11% (+¥0.20)
1M +7.08%
Market Cap ¥5.9B
P/E Ratio -
Div. Yield -
ROE 0.57%

Bulios Fair Price

¥5.46

43.6% downside

Current Price

¥9.68

Undervalued Fair Value Overvalued

According to Bulios Fair Price, 300463.SZ is currently overvalued relative to its market price. How does it work?

Piotroski F-Score Moderate
4/9
Valuation
54 /100
Fair
P/B 0.93x
EV/EBITDA 18.23x
P/S 2.72x
Growth
6 /100
Declining
Book val. growth 0.09%
Rev. growth 15.79%
FCF growth N/A
Profitability
17 /100
Weak
Op. margin 1.53%
Gross margin 42.93%
FCF margin 6.80%
Quality
4 /100
Poor
ROA 0.45%
ROIC 0.19%
Asset turnover 0.27x
Debt
77 /100
Low
Int. coverage -1.46x
Debt/Equity 0.16x
Net debt/EBITDA 0.92x
Stability
70 /100
Stable
EPS volatility 40.81%
Beta 0.90x
Profitable years 0
Ask StockBot about 300463.SZ
Online

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Wu Mingjian

Employees

2,875

Headquarters

Chengdu

Upcoming events

28 OCT

Earnings

Upcoming earnings report

72d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.